Curelab Oncology
curelaboncology.com
Health Care
Biologics & Biosimilars
Biotechnology
Claim pageClaim
Follow
Overview
Connections
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$3M
1 round on record
Latest round
$3M
Venture round · Aug 2022 · 4 yr ago
Team
11-50
employees, estimated range
The money's age
Long since its last round
50 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Aug 2022 | $3M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Curelab Oncology Inc | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Alex ShneiderExecutive OfficerSEC Form D
Charles LeggExecutive OfficerSEC Form D
Jason PayneExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Home Technology Antibody Drug Conjugates Innovative Platform - ‘OptiLinked’ FDCs Additional Products & Applications ANT-045, Antikor’s…
ABOUT US Overview Vision Our Leader SCIENCE Our Science Autoimmune Disease Our Platform R&D Strategy PIPELINE CAREER NEWS News&Notice…
Angitia is a clinical-stage biotechnology company focused on discovering and developing breakthrough therapeutics that address the key…
Case Studies About Contact Start Your Trial 8,045,092 regulatory pages 44 regulatory databases 10 regulatory agencies Overview We help our…
Attralus is focused on advancing new solutions for amyloidosis therapy. The team has deep experience in Amyloid research and therapeutic…
OUR TEAM FOUNDERS Dr. Moshik Cohen-Kutner Co-Founder And CEO Linkedin Dr. Niv Bachnoff Co-Founder And CSO Linkedin BOARD OF DIRECTORS Dr…
Overview
COMPANY NEWS October 21, 2026 October 21, 2026 CureLab Appoints Markus Puhlman, M.D., MBA, to Scientific Advisory Board Oncology development executive brings more than two decades of industry experience spanning clinical strategy, global regulatory submissions, and cancer research Do you like it?
People
Alex Shneider
Executive Officer
Charles Legg
Executive Officer
Jason Payne
Executive Officer
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Dedham
United States
HQ
10-50 est. staff
Financials
Total raised
$3M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2022 | $3M | Details |